
Pavmed Co., Ltd.: Innovating and distributing medical devices since 2004.
Pavmed Co., Ltd. is a commercial-stage, diversified medical technology company founded in 2004. Its core mission is to improve patient care and save lives through innovative medical devices. Pavmed's product portfolio includes advanced surgical instruments, diagnostic tools, and health monitoring systems. Key products include Lucid Diagnostics' EsoGuard, a mobile test unit for esophageal precancer detection, and Veris Health's integrated health monitoring solutions. The company focuses on revolutionizing patient care by challenging the status quo in the medical device industry.
Pavmed has made significant strides in medical technology, notably launching the first EsoGuard mobile test unit for early detection of esophageal precancer. This innovation underscores its commitment to enhancing diagnostic accuracy and accessibility. Pavmed's impact is evident in its contributions to early disease detection and patient monitoring, which have the potential to save lives and improve health outcomes. The company's leadership and strategic vision continue to drive its growth and influence in the medical technology sector.

Lucid Diagnostics
luciddx.com

Pavad Medical

Precision Medical Products
pmpmed.com

Promedix
promedixinc.com

Avanos Medical
avanos.com

Oui-Medical.
oui-medical.com

Piraeus Medical

MediPines
medipines.com

Avicena
avicenaheart.com

MobileMedTek
Nano Mobile Healthcare

eLum Technologies

Portela Soni Medical

Eva
edenmed.com

Somavac Medical Solutions
somavac.com
Companies similar to Pavmed include Lucid Diagnostics, Pavad Medical, Precision Medical Products and Promedix.
Pavmed was founded in 2014.
Pavmed's headquarters is located in New York City, NY, US.
Pavmed's most recent funding round was for $50M (USD) in April 2022.
As of Apr 7, 2022, Pavmed has raised a total of $69M (USD).
Pavmed has 124 employees as of Feb 6, 2024.